MedPath

Fluart Innovative Vaccine Ltd, Hungary

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:0
Completed:11

Trial Phases

4 Phases

Phase 1:1
Phase 3:1
Phase 4:3
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Not Applicable
6 (54.5%)
Phase 4
3 (27.3%)
Phase 1
1 (9.1%)
Phase 3
1 (9.1%)

Safety of 4Fluart ID Suspension for Injection in Adult Subjects

Phase 1
Completed
Conditions
Human Influenza
First Posted Date
2018-02-28
Last Posted Date
2021-03-03
Lead Sponsor
Fluart Innovative Vaccine Ltd, Hungary
Target Recruit Count
36
Registration Number
NCT03448705
Locations
🇭🇺

Drug Research Center, Balatonfüred, Veszprém, Hungary

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

Phase 3
Completed
Conditions
Human Influenza
First Posted Date
2015-03-13
Last Posted Date
2021-03-11
Lead Sponsor
Fluart Innovative Vaccine Ltd, Hungary
Target Recruit Count
120
Registration Number
NCT02387294

Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection

Phase 4
Completed
Conditions
Influenza Prophylaxis
First Posted Date
2013-05-29
Last Posted Date
2021-04-05
Lead Sponsor
Fluart Innovative Vaccine Ltd, Hungary
Target Recruit Count
120
Registration Number
NCT01863849
Locations
🇭🇺

Family Doctor's Office, Budapest, Hungary

🇭🇺

District Doctor's Office, Szentendre, Hungary

Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season

Phase 4
Completed
Conditions
Influenza
Interventions
Drug: Fluval AB vaccination
First Posted Date
2012-07-25
Last Posted Date
2012-10-12
Lead Sponsor
Fluart Innovative Vaccine Ltd, Hungary
Target Recruit Count
120
Registration Number
NCT01649713
Locations
🇭🇺

District Doctor's Office, Szentendre, Hungary

A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects

Not Applicable
Completed
Conditions
Influenza
First Posted Date
2011-10-25
Last Posted Date
2012-05-21
Lead Sponsor
Fluart Innovative Vaccine Ltd, Hungary
Target Recruit Count
1206
Registration Number
NCT01459276
Locations
🇭🇺

Péter Vajer, Biatorbágy, Pest, Hungary

🇭🇺

Barna Bőze, Hatvan, Pest, Hungary

🇭🇺

Family Doctor's Office, Pilisvörösvár, Hungary

and more 1 locations
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.